TEV-408
- Generic Name
- TEV-408
A Trial to Assess the Efficacy and Safety of TEV-53408 in Adults With Celiac Disease
- First Posted Date
- 2025-02-04
- Last Posted Date
- 2025-05-22
- Lead Sponsor
- Teva Branded Pharmaceutical Products R&D LLC
- Target Recruit Count
- 48
- Registration Number
- NCT06807463
- Locations
- ๐บ๐ธ
Teva Investigational Site 12134, Inverness, Florida, United States
๐บ๐ธTeva Investigational Site 12126, Miami Lakes, Florida, United States
๐บ๐ธTeva Investigational Site 12131, Colorado Springs, Colorado, United States
A Trial to Test the Safety and Efficacy of TEV-53408 in Treating Vitiligo
- First Posted Date
- 2024-10-03
- Last Posted Date
- 2025-03-24
- Lead Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Target Recruit Count
- 28
- Registration Number
- NCT06625177
- Locations
- ๐บ๐ธ
Teva Investigational Site 12054, Portland, Oregon, United States
๐บ๐ธTeva Investigational Site 12043, Scottsdale, Arizona, United States
๐บ๐ธTeva Investigational Site 12052, Hot Springs, Arkansas, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
ยฉ Copyright 2025. All Rights Reserved by MedPath